Citigroup
SFE

Citigroup’s Safeguard Scientifics, Inc. SFE Stock Holding History

Citigroup’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-23,106
Closed -$205K – 6148
2021
Q3 		$205K Buy
23,106
+22,473
+3,550% +$180K ﹤0.01% 4106
2021
Q2 		$5K Sell
633
-1,315
-68% -$8.97K ﹤0.01% 5860
2021
Q1 		$13K Sell
1,948
-2,590
-57% -$18.8K ﹤0.01% 5506
2020
Q4 		$29K Buy
4,538
+3,331
+276% +$20.8K ﹤0.01% 6424
2020
Q3 		$7K Sell
1,207
-1,870
-61% -$11.2K ﹤0.01% 6861
2020
Q2 		$22K Sell
3,077
-3,094
-50% -$19.6K ﹤0.01% 6558
2020
Q1 		$34K Buy
6,171
+1,567
+34% +$14K ﹤0.01% 6334
2019
Q4 		$51K Sell
4,604
-5,343
-54% -$61.1K ﹤0.01% 6297
2019
Q3 		$113K Buy
9,947
+4,461
+81% +$53.2K ﹤0.01% 5587
2019
Q2 		$67K Buy
5,486
+187
+4% +$2.19K ﹤0.01% 6226
2019
Q1 		$57K Buy
5,299
+212
+4% +$2.15K ﹤0.01% 6237
2018
Q4 		$44K Sell
5,087
-220
-4% -$1.92K ﹤0.01% 6338
2018
Q3 		$49K Buy
5,307
+3,105
+141% +$33.7K ﹤0.01% 6537
2018
Q2 		$28K Sell
2,202
-1,916
-47% -$24.7K ﹤0.01% 6754
2018
Q1 		$51K Sell
4,118
-10
-0.2% -$122 ﹤0.01% 6162
2017
Q4 		$46K Buy
4,128
+2,936
+246% +$37.6K ﹤0.01% 6243
2017
Q3 		$16K Sell
1,192
-72
-6% -$887 ﹤0.01% 6538
2017
Q2 		$15K Buy
1,264
+416
+49% +$4.9K ﹤0.01% 6396
2017
Q1 		$11K Sell
848
-19,623
-96% -$247K ﹤0.01% 6535
2016
Q4 		$276K Buy
20,471
+18,643
+1,020% +$230K ﹤0.01% 5011
2016
Q3 		$24K Buy
1,828
+1,758
+2,511% +$23.3K ﹤0.01% 6118
2016
Q2 		$1K Sell
70
-14,756
-100% -$198K ﹤0.01% 7007
2016
Q1 		$197K Buy
14,826
+11,065
+294% +$139K ﹤0.01% 5103
2015
Q4 		$55K Buy
3,761
+3,363
+845% +$54.3K ﹤0.01% 5872
2015
Q3 		$6K Sell
398
-120
-23% -$2.15K ﹤0.01% 6672
2015
Q2 		$10K Sell
518
-961
-65% -$17.6K ﹤0.01% 6478
2015
Q1 		$27K Sell
1,479
-2,460
-62% -$45.5K ﹤0.01% 5917
2014
Q4 		$78K Buy
3,939
+3,151
+400% +$60.7K ﹤0.01% 5406
2014
Q3 		$15K Buy
788
+129
+20% +$2.55K ﹤0.01% 6068
2014
Q2 		$14K Sell
659
-2,620
-80% -$52.7K ﹤0.01% 6020
2014
Q1 		$73K Sell
3,279
-4,633
-59% -$92.1K ﹤0.01% 5240
2013
Q4 		$159K Buy
7,912
+3,231
+69% +$57.2K ﹤0.01% 4862
2013
Q3 		$73K Sell
4,681
-5,419
-54% -$83.4K ﹤0.01% 4977
2013
Q2 		$163K Buy
+10,100
New +$161K ﹤0.01% 4440

Other funds holding SFE

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
CCM
Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return

Citigroup's SFE Position: Q4 2021 in Review

Citigroup sold out of Safeguard Scientifics, Inc. (SFE) in Q4 2021, closing a stake of 23,106 shares — an estimated $205K sold.

Citigroup first reported a position in SFE in Q2 2013 and held it in 34 quarters. The position peaked at $276K in Q4 2016. 63 funds tracked by Wall St. Rank hold SFE as of Q4 2021.

  • Citigroup reported no remaining Safeguard Scientifics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Citigroup sold 23,106 Safeguard Scientifics, Inc. shares in Q4 2021, an estimated $205K.
  • Citigroup first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 34 quarters.
  • Citigroup's Safeguard Scientifics, Inc. position peaked at $276K in Q4 2016.
  • 63 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q4 2021.

Based on Citigroup's 13F filing for Q4 2021, filed 10 Feb 2022.